Perrigo appoints CFO
A drug maker in the region has selected its chief financial officer.
Dublin-based Perrigo Company, which operates its North American headquarters in Allegan, appointed Ron Winowiecki to the role.
Winowiecki has been serving as acting CFO since February 2017 following the departure of former CFO Judy Brown.
Uwe Röhrhoff, Perrigo’s president and CEO since January, said Winowiecki proved himself to be the right person for the job during the past year.
“Ron has a proven track record of developing and leading our global finance organization through many significant milestones during his nine-year tenure at Perrigo,” Röhrhoff said.
“His leadership, transparency and intimate knowledge of Perrigo’s businesses will help shape the strategic vision of our company.”
Winowiecki joined Perrigo in 2008 and has held several senior management roles within the company’s finance and accounting organization.
These include vice president of Perrigo’s treasury and accounting shared services and corporate controller.
He was senior vice president of business finance prior to serving as acting CFO.
Before joining Perrigo, he was CFO for Innotec Co., vice president and corporate controller for SPX Corp., and corporate controller and chief accounting officer at Donnelly Corp.
Winowiecki earned a bachelor’s degree in accounting from Hope College and an MBA in finance from Western Michigan University.
Perrigo Co. (NYSE: PRGO), a global over-the-counter consumer goods and pharmaceutical company, was founded in Allegan in 1887 as a packager of generic home remedies.
Now headquartered in Dublin, the company makes OTC products and supplies infant formulas and topical medications across a variety of product categories and geographies in North America, Europe and Australia, as well as Israel and China.